Abbott (ABT.US) Q3 revenue beats expectations but lowers full-year guidance; plans to spin off its nutrition business for public listing

According to Golden Ten Data, Abbott (ABT.US) announced its results for the third quarter of 2026 on Wednesday, showing that sales for the quarter rose 15% year-on-year to $13.01 billion, exceeding market expectations of $12.99 billion; adjusted earnings per share were $1.42, a year-on-year increase of 9%, in line with market expectations; gross margin increased from about 56% in the same period last year to about 57%.